Actualités Hemostemix Inc - HEM | Actions TSX Venture Exchange

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Hemostemix Announces Appointment of Director

CALGARY, Alberta, Nov. 29, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX...

Hemostemix Announces Director Resignation

CALGARY, Alberta, Nov. 22, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX...

Hemostemix Provides Corporate Update

CALGARY, Alberta, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX...

Hemostemix Provides Corporate Update

CALGARY, Alberta, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX...

Hemostemix Announces Positive Results and Conclusions Reported in Phase II CLI Trial Abstract

CALGARY, Alberta, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX...

Hemostemix Announces Commencement of Arbitration

CALGARY, Alberta, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX...

Hemostemix Announces $2 Million Loan Facility

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Aug...

Hemostemix Announces Financing Update and Interim CFO Appointment

CALGARY, Alberta, July 11, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX...

Hemostemix Announces Ongoing Phase II CLI Trial Abstract Accepted for Presentation by Canadian Society for Vascular Surgery

CALGARY, Alberta, July 02, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Hemostemix Inc (HEM)

Votre Hub pour des idées et discussions en direct en temps réel

HEM Actualités

Hemostemix Announces Appointment of Director

Hemostemix Announces Director Resignation

Hemostemix Provides Corporate Update

Hemostemix Provides Corporate Update

Hemostemix Announces Positive Results and Conclusions Reported in Phase II CLI Trial Abstract

Hemostemix Announces Commencement of Arbitration

Hemostemix Announces $2 Million Loan Facility

Hemostemix Announces Financing Update and Interim CFO Appointment

Hemostemix Announces Ongoing Phase II CLI Trial Abstract Accepted for Presentation by Canadian Society for Vascular Surgery

Hemostemix Announces Enrollment Update for the ACP-01 Phase II Critical Limb Ischemia Clinical Trial

Hemostemix Announces Resignation of CFO

Hemostemix Closes First Tranche of Financing

Hemostemix Announces Convertible Debenture Financing

Hemostemix Announces Convertible Debenture Financing

Hemostemix Announces Enrollment Milestone in the ACP-01 Phase II Critical Limb Ischemia Clinical Trial

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Hemostemix Inc (HEM) Actualités

Hemostemix Inc (HEM)

Votre Hub pour des idées et discussions en direct en temps réel

HEM Actualités

Hemostemix Announces Appointment of Director

Hemostemix Announces Director Resignation

Hemostemix Provides Corporate Update

Hemostemix Provides Corporate Update

Hemostemix Announces Positive Results and Conclusions Reported in Phase II CLI Trial Abstract

Hemostemix Announces Commencement of Arbitration

Hemostemix Announces $2 Million Loan Facility

Hemostemix Announces Financing Update and Interim CFO Appointment

Hemostemix Announces Ongoing Phase II CLI Trial Abstract Accepted for Presentation by Canadian Society for Vascular Surgery

Hemostemix Announces Enrollment Update for the ACP-01 Phase II Critical Limb Ischemia Clinical Trial

Hemostemix Announces Resignation of CFO

Hemostemix Closes First Tranche of Financing

Hemostemix Announces Convertible Debenture Financing

Hemostemix Announces Convertible Debenture Financing

Hemostemix Announces Enrollment Milestone in the ACP-01 Phase II Critical Limb Ischemia Clinical Trial

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application